UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Nocturnal asthma

Author
Richard J Martin, MD
Section Editors
Peter J Barnes, DM, DSc, FRCP, FRS
Robert A Wood, MD
Deputy Editor
Helen Hollingsworth, MD

INTRODUCTION

Nocturnal worsening of asthma is a well-described and important problem that must be considered in the management of patients with asthma [1]. In particular, nocturnal asthma symptoms are felt to be a characteristic feature of asthma that is not well-controlled [2,3].

An overview of nocturnal asthma will be reviewed here. An overview of asthma management and the treatment of moderate persistent and severe persistent asthma are discussed separately. (See "An overview of asthma management" and "Treatment of moderate persistent asthma in adolescents and adults" and "Treatment of severe asthma in adolescents and adults".)

EPIDEMIOLOGY

Nocturnal asthma is common and approximately 30 to 70 percent of patients with asthma report nocturnal asthma symptoms at least once a month [4-7].

In a cross-sectional survey of 13,493 patients with persistent asthma, prevalence of nocturnal symptoms was 60 percent [8].

Among 1041 children with mild-to-moderate asthma followed in the Childhood Asthma Management Program, 34 percent experienced one or more nocturnal awakenings in the 28-day screening period [7].

                            

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Mon Jun 01 00:00:00 GMT+00:00 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988; 85:6.
  2. National Asthma Education and Prevention Program: Expert panel report III. Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051) www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm (Accessed on August 27, 2013).
  3. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). www.ginasthma.org (Accessed on January 30, 2015).
  4. Storms WW, Bodman SF, Nathan RA, Byer P. Nocturnal asthma symptoms may be more prevalent than we think. J Asthma 1994; 31:313.
  5. Fagnano M, Bayer AL, Isensee CA, et al. Nocturnal asthma symptoms and poor sleep quality among urban school children with asthma. Acad Pediatr 2011; 11:493.
  6. El-Saify MY, Shaheen MA, Sabbour SM, Basal AA. Nocturnal attacks, emergency room visits and ICU admission of pediatric asthma: frequency and associated factors. J Egypt Public Health Assoc 2008; 83:353.
  7. Strunk RC, Sternberg AL, Bacharier LB, Szefler SJ. Nocturnal awakening caused by asthma in children with mild-to-moderate asthma in the childhood asthma management program. J Allergy Clin Immunol 2002; 110:395.
  8. Raherison C, Abouelfath A, Le Gros V, et al. Underdiagnosis of nocturnal symptoms in asthma in general practice. J Asthma 2006; 43:199.
  9. Horner CC, Mauger D, Strunk RC, et al. Most nocturnal asthma symptoms occur outside of exacerbations and associate with morbidity. J Allergy Clin Immunol 2011; 128:977.
  10. Levin AM, Wang Y, Wells KE, et al. Nocturnal asthma and the importance of race/ethnicity and genetic ancestry. Am J Respir Crit Care Med 2014; 190:266.
  11. Robertson CF, Rubinfeld AR, Bowes G. Deaths from asthma in Victoria: a 12-month survey. Med J Aust 1990; 152:511.
  12. Martin RJ, Banks-Schlegel S. Chronobiology of asthma. Am J Respir Crit Care Med 1998; 158:1002.
  13. Hetzel MR, Clark TJ. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 1980; 35:732.
  14. Sutherland ER. Nocturnal asthma: underlying mechanisms and treatment. Curr Allergy Asthma Rep 2005; 5:161.
  15. Sutherland ER. Nocturnal asthma. J Allergy Clin Immunol 2005; 116:1179.
  16. Barnes P, FitzGerald G, Brown M, Dollery C. Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. N Engl J Med 1980; 303:263.
  17. Sutherland ER, Ellison MC, Kraft M, Martin RJ. Altered pituitary-adrenal interaction in nocturnal asthma. J Allergy Clin Immunol 2003; 112:52.
  18. Sutherland ER, Ellison MC, Kraft M, Martin RJ. Elevated serum melatonin is associated with the nocturnal worsening of asthma. J Allergy Clin Immunol 2003; 112:513.
  19. Sutherland ER, Martin RJ. Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma. J Allergy Clin Immunol 2003; 112:819.
  20. Morrison JF, Pearson SB, Dean HG. Parasympathetic nervous system in nocturnal asthma. Br Med J (Clin Res Ed) 1988; 296:1427.
  21. Kallenbach JM, Webster T, Dowdeswell R, et al. Reflex heart rate control in asthma. Evidence of parasympathetic overactivity. Chest 1985; 87:644.
  22. Irvin CG, Pak J, Martin RJ. Airway-parenchyma uncoupling in nocturnal asthma. Am J Respir Crit Care Med 2000; 161:50.
  23. Barnes PJ, Chung KF, Page CP. Inflammatory mediators and asthma. Pharmacol Rev 1988; 40:49.
  24. deVries, K, Goei, JT, Booy-Noord, H, et al. Changes during 24 hours in the lung function and histamine hyperactivity of the bronchial tree in asthmatic and bronchitic patients. Arch Allergy Appl Immunol 1962; 20:93.
  25. Martin RJ, Cicutto LC, Ballard RD. Factors related to the nocturnal worsening of asthma. Am Rev Respir Dis 1990; 141:33.
  26. Kraft M, Djukanovic R, Wilson S, et al. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996; 154:1505.
  27. Kraft M, Striz I, Georges G, et al. Expression of epithelial markers in nocturnal asthma. J Allergy Clin Immunol 1998; 102:376.
  28. Kraft M, Martin RJ, Wilson S, et al. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med 1999; 159:228.
  29. Martin RJ, Cicutto LC, Smith HR, et al. Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991; 143:351.
  30. Jarjour NN, Busse WW, Calhoun WJ. Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Respir Dis 1992; 146:905.
  31. Doi S, Murayama N, Inoue T, et al. CD4 T-lymphocyte activation is associated with peak expiratory flow variability in childhood asthma. J Allergy Clin Immunol 1996; 97:955.
  32. Hauber HP, Gotfried M, Newman K, et al. Effect of HFA-flunisolide on peripheral lung inflammation in asthma. J Allergy Clin Immunol 2003; 112:58.
  33. Gillissen A, Richter A, Oster H, Criée CP. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma. J Physiol Pharmacol 2007; 58 Suppl 5:233.
  34. Beam WR, Weiner DE, Martin RJ. Timing of prednisone and alterations of airways inflammation in nocturnal asthma. Am Rev Respir Dis 1992; 146:1524.
  35. Wenzel SE, Trudeau JB, Kaminsky DA, et al. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med 1995; 152:897.
  36. Jarjour NN, Busse WW. Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma. Am J Respir Crit Care Med 1995; 152:1474.
  37. Szefler SJ, Ando R, Cicutto LC, et al. Plasma histamine, epinephrine, cortisol, and leukocyte beta-adrenergic receptors in nocturnal asthma. Clin Pharmacol Ther 1991; 49:59.
  38. Bellia V, Bonanno A, Cibella F, et al. Urinary leukotriene E4 in the assessment of nocturnal asthma. J Allergy Clin Immunol 1996; 97:735.
  39. Kraft M, Vianna E, Martin RJ, Leung DY. Nocturnal asthma is associated with reduced glucocorticoid receptor binding affinity and decreased steroid responsiveness at night. J Allergy Clin Immunol 1999; 103:66.
  40. Desjardin JA, Sutarik JM, Suh BY, Ballard RD. Influence of sleep on pulmonary capillary volume in normal and asthmatic subjects. Am J Respir Crit Care Med 1995; 152:193.
  41. Contopoulos-Ioannidis DG, Manoli EN, Ioannidis JP. Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. J Allergy Clin Immunol 2005; 115:963.
  42. Turki J, Pak J, Green SA, et al. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995; 95:1635.
  43. D'Alonzo GE, Steinijans VW, Keller A. Measurements of morning and evening airflow grossly underestimate the circadian variability of FEV1 and peak expiratory flow rate in asthma. Am J Respir Crit Care Med 1995; 152:1097.
  44. Booij-Noord H, de Vries K, Sluiter HJ, Orie NG. Late bronchial obstructive reaction to experimental inhalation of house dust extract. Clin Allergy 1972; 2:43.
  45. Robertson DG, Kerigan AT, Hargreave FE, et al. Late asthmatic responses induced by ragweed pollen allergen. J Allergy Clin Immunol 1974; 54:244.
  46. Mohiuddin AA, Martin RJ. Circadian basis of the late asthmatic response. Am Rev Respir Dis 1990; 142:1153.
  47. Teodorescu M, Polomis DA, Teodorescu MC, et al. Association of obstructive sleep apnea risk or diagnosis with daytime asthma in adults. J Asthma 2012; 49:620.
  48. Teodorescu M, Barnet JH, Hagen EW, et al. Association between asthma and risk of developing obstructive sleep apnea. JAMA 2015; 313:156.
  49. Mastronarde JG, Wise RA, Shade DM, et al. Sleep quality in asthma: results of a large prospective clinical trial. J Asthma 2008; 45:183.
  50. Boezen HM, Postma DS, Schouten JP, et al. PEF variability, bronchial responsiveness and their relation to allergy markers in a random population (20-70 yr). Am J Respir Crit Care Med 1996; 154:30.
  51. Epton MJ, Martin IR, Graham P, et al. Climate and aeroallergen levels in asthma: a 12 month prospective study. Thorax 1997; 52:528.
  52. Sullivan CE, Murphy E, Kozar LF, Phillipson EA. Waking and ventilatory responses to laryngeal stimulation in sleeping dogs. J Appl Physiol Respir Environ Exerc Physiol 1978; 45:681.
  53. Brugman SM, Larsen GL, Henson PM, et al. Increased lower airways responsiveness associated with sinusitis in a rabbit model. Am Rev Respir Dis 1993; 147:314.
  54. Gislason T, Janson C, Vermeire P, et al. Respiratory symptoms and nocturnal gastroesophageal reflux: a population-based study of young adults in three European countries. Chest 2002; 121:158.
  55. Harding SM, Schan CA, Guzzo MR, et al. Gastroesophageal reflux-induced bronchoconstriction. Is microaspiration a factor? Chest 1995; 108:1220.
  56. Tan WC, Martin RJ, Pandey R, Ballard RD. Effects of spontaneous and simulated gastroesophageal reflux on sleeping asthmatics. Am Rev Respir Dis 1990; 141:1394.
  57. Ford GA, Oliver PS, Prior JS, et al. Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastro-oesophageal reflux: a placebo-controlled cross-over study. Postgrad Med J 1994; 70:350.
  58. Chan CS, Woolcock AJ, Sullivan CE. Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis 1988; 137:1502.
  59. NADEL JA, WIDDICOMBE JG. Reflex effects of upper airway irritation on total lung resistance and blood pressure. J Appl Physiol 1962; 17:861.
  60. Martin RJ, Pak J. Nasal CPAP in nonapneic nocturnal asthma. Chest 1991; 100:1024.
  61. Pincus DJ, Szefler SJ, Ackerson LM, Martin RJ. Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1995; 95:1172.
  62. Pincus DJ, Humeston TR, Martin RJ. Further studies on the chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1997; 100:771.
  63. Fitzpatrick MF, Mackay T, Driver H, Douglas NJ. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. BMJ 1990; 301:1365.
  64. Dahl R, Earnshaw JS, Palmer JB. Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease. Eur Respir J 1991; 4:1178.
  65. Holimon TD, Chafin CC, Self TH. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists? Drugs 2001; 61:391.
  66. Lockey RF, DuBuske LM, Friedman B, et al. Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes. Chest 1999; 115:666.
  67. Martin RJ, Cicutto LC, Ballard RD, et al. Circadian variations in theophylline concentrations and the treatment of nocturnal asthma. Am Rev Respir Dis 1989; 139:475.
  68. Welsh PW, Reed CE, Conrad E. Timing of once-a-day theophylline dose to match peak blood level with diurnal variation in severity of asthma. Am J Med 1986; 80:1098.
  69. Kraft M, Torvik JA, Trudeau JB, et al. Theophylline: potential antiinflammatory effects in nocturnal asthma. J Allergy Clin Immunol 1996; 97:1242.
  70. Selby C, Engleman HM, Fitzpatrick MF, et al. Inhaled salmeterol or oral theophylline in nocturnal asthma? Am J Respir Crit Care Med 1997; 155:104.
  71. Spector SL, Smith LJ, Glass M. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group. Am J Respir Crit Care Med 1994; 150:618.
  72. Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 1999; 130:487.
  73. Esmailpour N, Högger P, Rabe KF, et al. Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo. Eur Respir J 1997; 10:1496.
  74. Sutherland ER, Martin RJ, Bowler RP, et al. Physiologic correlates of distal lung inflammation in asthma. J Allergy Clin Immunol 2004; 113:1046.
  75. Goldin JG, Tashkin DP, Kleerup EC, et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol 1999; 104:S258.
  76. Worth H. A comparison of HFA-BDP Autohaler with budesonide Turbuhaler in asthma control of adult patients with mild to moderately severe disease. Respir Med 2000; 94 Suppl D:S27.
  77. Reinberg A, Halberg F, Falliers CJ. Circadian timing of methylprednisolone effects in asthmatic boys. Chronobiologia 1974; 1:333.
  78. Reinberg A, Gervais P, Chaussade M, et al. Circadian changes in effectiveness of corticosteroids in eight patients with allergic asthma. J Allergy Clin Immunol 1983; 71:425.
  79. Reinberg A, Guillet P, Gervais P, et al. One month chronocorticotherapy (Dutimelan 8 15 mite). Control of the asthmatic condition without adrenal suppression and circadian rhythm alteration. Chronobiologia 1977; 4:295.